Bompadre Silvia G, Cho Jeong Han, Wang Xiaohui, Zou Xiaoqin, Sohma Yoshiro, Li Min, Hwang Tzyh-Chang
Department of Medical Pharmacology and Physiology, University of Missouri-Columbia 65211, USA.
J Gen Physiol. 2005 Apr;125(4):377-94. doi: 10.1085/jgp.200409228. Epub 2005 Mar 14.
Previously, we demonstrated that ADP inhibits cystic fibrosis transmembrane conductance regulator (CFTR) opening by competing with ATP for a binding site presumably in the COOH-terminal nucleotide binding domain (NBD2). We also found that the open time of the channel is shortened in the presence of ADP. To further study this effect of ADP on the open state, we have used two CFTR mutants (D1370N and E1371S); both have longer open times because of impaired ATP hydrolysis at NBD2. Single-channel kinetic analysis of DeltaR/D1370N-CFTR shows unequivocally that the open time of this mutant channel is decreased by ADP. DeltaR/E1371S-CFTR channels can be locked open by millimolar ATP with a time constant of approximately 100 s, estimated from current relaxation upon nucleotide removal. ADP induces a shorter locked-open state, suggesting that binding of ADP at a second site decreases the locked-open time. To test the functional consequence of the occupancy of this second nucleotide binding site, we changed the [ATP] and performed similar relaxation analysis for E1371S-CFTR channels. Two locked-open time constants can be discerned and the relative distribution of each component is altered by changing [ATP] so that increasing [ATP] shifts the relative distribution to the longer locked-open state. Single-channel kinetic analysis for DeltaR/E1371S-CFTR confirms an [ATP]-dependent shift of the distribution of two locked-open time constants. These results support the idea that occupancy of a second ATP binding site stabilizes the locked-open state. This binding site likely resides in the NH2-terminal nucleotide binding domain (NBD1) because introducing the K464A mutation, which decreases ATP binding affinity at NBD1, into E1371S-CFTR shortens the relaxation time constant. These results suggest that the binding energy of nucleotide at NBD1 contributes to the overall energetics of the open channel conformation.
此前,我们证明了ADP通过与ATP竞争一个可能位于COOH末端核苷酸结合结构域(NBD2)的结合位点来抑制囊性纤维化跨膜传导调节因子(CFTR)的开放。我们还发现,在存在ADP的情况下,通道的开放时间会缩短。为了进一步研究ADP对开放状态的这种影响,我们使用了两个CFTR突变体(D1370N和E1371S);由于NBD2处的ATP水解受损,两者的开放时间都更长。对DeltaR/D1370N-CFTR的单通道动力学分析明确显示,ADP会缩短该突变通道的开放时间。DeltaR/E1371S-CFTR通道可以被毫摩尔浓度的ATP锁定在开放状态,根据核苷酸去除后电流弛豫估算,其时间常数约为100秒。ADP会诱导出一个较短的锁定开放状态,这表明ADP在第二个位点的结合会缩短锁定开放时间。为了测试这个第二个核苷酸结合位点被占据的功能后果,我们改变了[ATP]浓度,并对E1371S-CFTR通道进行了类似的弛豫分析。可以辨别出两个锁定开放时间常数,并且通过改变[ATP]浓度,每个组分的相对分布会发生改变,使得[ATP]浓度增加会使相对分布向更长的锁定开放状态转变。对DeltaR/E1371S-CFTR的单通道动力学分析证实了两个锁定开放时间常数的分布存在[ATP]浓度依赖性的转变。这些结果支持了这样一种观点,即第二个ATP结合位点的占据会稳定锁定开放状态。这个结合位点可能位于NH2末端核苷酸结合结构域(NBD1),因为将降低NBD1处ATP结合亲和力的K464A突变引入E1371S-CFTR会缩短弛豫时间常数。这些结果表明,NBD1处核苷酸的结合能有助于开放通道构象的整体能量学。